PresentationsAddiction medicine

ISAM 2026 · Rotterdam, 2026

Kamini Use in Canada

An emerging substance of concern identified in Alberta: a herbal product that can carry opium-derived opioids, dependence and lead toxicity.

Presented at
ISAM 2026
Location
Rotterdam
Year
2026
Format
Talk + E-poster
  1. Slide 1 of 15: Kamini Use in Canada
  2. Slide 2 of 15: Kamini Use in Canada
  3. Slide 3 of 15: Kamini Use in Canada
  4. Slide 4 of 15: Kamini Use in Canada
  5. Slide 5 of 15: Kamini Use in Canada
  6. Slide 6 of 15: Kamini Use in Canada
  7. Slide 7 of 15: Kamini Use in Canada
  8. Slide 8 of 15: Kamini Use in Canada
  9. Slide 9 of 15: Kamini Use in Canada
  10. Slide 10 of 15: Kamini Use in Canada
  11. Slide 11 of 15: Kamini Use in Canada
  12. Slide 12 of 15: Kamini Use in Canada
  13. Slide 13 of 15: Kamini Use in Canada
  14. Slide 14 of 15: Kamini Use in Canada
  15. Slide 15 of 15: Kamini Use in Canada

1 / 15

Open PDF Download

Key messages

  1. Kamini can represent an opioid exposure, not simply an “herbal” remedy.

  2. Dependence and clinically significant withdrawal are documented.

  3. Lead toxicity is an additional concern in compatible presentations.

  4. Ask about it specifically, treat the opioid use disorder and improve surveillance.

Prepared for healthcare professionals. These presentations summarize clinical evidence and experience for colleagues. They are not advice about your own care; please speak with your physician.